These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 1886511
1. [Metolazone in the treatment of advanced therapy-resistant dilated cardiomyopathy]. Kröger N, Szuba J, Frenzel H. Med Klin (Munich); 1991 Jun 15; 86(6):305-8, 332. PubMed ID: 1886511 [Abstract] [Full Text] [Related]
3. [Furosemide and metolazone: a highly effective diuretic combination]. Furrer J, Hess OM, Kuhlmann U, Satz N, Siegenthaler W. Schweiz Med Wochenschr; 1980 Nov 29; 110(48):1825-9. PubMed ID: 7280609 [Abstract] [Full Text] [Related]
4. Efficacy of metolazone and furosemide in children with furosemide-resistant edema. Arnold WC. Pediatrics; 1984 Nov 29; 74(5):872-5. PubMed ID: 6493882 [Abstract] [Full Text] [Related]
6. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S. Am Heart J; 2003 Mar 29; 145(3):459-66. PubMed ID: 12660669 [Abstract] [Full Text] [Related]
7. Combination of metolazone and furosemide in the treatment of edema in the first month of life. Cachero SD, Lofland G, Springate JE, Feld LG. Child Nephrol Urol; 1990 Mar 29; 10(3):161-3. PubMed ID: 2285924 [Abstract] [Full Text] [Related]
9. Metolazone in treatment of severe refractory congestive cardiac failure. Kiyingi A, Field MJ, Pawsey CC, Yiannikas J, Lawrence JR, Arter WJ. Lancet; 1990 Jan 06; 335(8680):29-31. PubMed ID: 1967337 [Abstract] [Full Text] [Related]
10. Treatment of subclinical fluid retention in patients with symptomatic heart failure: effect on exercise performance. Chomsky DB, Lang CC, Rayos G, Wilson JR. J Heart Lung Transplant; 1997 Aug 06; 16(8):846-53. PubMed ID: 9286777 [Abstract] [Full Text] [Related]
11. Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial. Cox ZL, Hung R, Lenihan DJ, Testani JM. JACC Heart Fail; 2020 Mar 06; 8(3):157-168. PubMed ID: 31838029 [Abstract] [Full Text] [Related]
13. Diuresis Efficacy in Ambulatory Congested Heart Failure Patients: Intrapatient Comparison of 3 Diuretic Regimens (DEA-HF). Abbo AR, Gruber A, Volis I, Aronson D, Girerd N, Lund Kristensen S, Zukermann R, Alberkant N, Sitnitsky E, Kruger A, Khasis P, Bravo E, Elad B, Helmer Levin L, Caspi O. JACC Heart Fail; 2024 Aug 06; 12(8):1396-1405. PubMed ID: 38739124 [Abstract] [Full Text] [Related]
14. The evaluation of the diuretic action of parenteral formulations of metolazone. Cvetanovic I, Ranade V, Molnar J, Whelton A, Somberg J. Am J Ther; 2007 Aug 06; 14(1):25-9. PubMed ID: 17303972 [Abstract] [Full Text] [Related]
16. Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. Salahudin M, Shah H, Jan MU, Altaf A. J Pak Med Assoc; 2019 Dec 06; 69(12):1794-1799. PubMed ID: 31853105 [Abstract] [Full Text] [Related]
17. Clinical studies of a new, low-dose formulation of metolazone for the treatment of hypertension. Curry CL, Janda SM, Harris R, MacKay JH, Nugent CA, Ryan J, Schnaper H, Schoenberger J. Clin Ther; 1986 Dec 06; 9(1):47-62. PubMed ID: 3545477 [Abstract] [Full Text] [Related]
20. Early and medium term results of tailored therapy for heart failure. Martins S, Soares RM, do Rosário L, Quininha J, Antunes AM. Rev Port Cardiol; 2001 Mar 06; 20(3):261-82. PubMed ID: 11417309 [Abstract] [Full Text] [Related] Page: [Next] [New Search]